Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation
Open Access
- 7 May 2014
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Systems Neuroscience
- Vol. 8, 70
Abstract
Methamphetamine (MA) is a highly addictive psychomotor stimulant, with life-time prevalence rates of abuse ranging from 5–10% world-wide. Yet, a paucity of research exists regarding MA addiction vulnerability/resiliency and neurobiological mediators of the transition to addiction that might occur upon repeated low-dose MA exposure, more characteristic of early drug use. As stimulant-elicited neuroplasticity within dopamine neurons innervating the nucleus accumbens (NAC) and prefrontal cortex (PFC) is theorized as central for addiction-related behavioral anomalies, we used a multi-disciplinary research approach in mice to examine the interactions between sub-toxic MA dosing, motivation for MA and mesocorticolimbic monoamines. Biochemical studies of C57BL/6J (B6) mice revealed short- (1 day), as well as longer-term (21 days), changes in extracellular dopamine, DAT and/or D2 receptors during withdrawal from 10, once daily, 2 mg/kg MA injections. Follow-up biochemical studies conducted in mice selectively bred for high vs. low MA drinking (respectively, MAHDR vs. MALDR mice), provided novel support for anomalies in mesocorticolimbic dopamine as a correlate of genetic vulnerability to high MA intake. Finally, neuropharmacological targeting of NAC dopamine in MA-treated B6 mice demonstrated a bi-directional regulation of MA-induced place-conditioning. These results extend extant literature for MA neurotoxicity by demonstrating that even subchronic exposure to relatively low MA doses are sufficient to elicit relatively long-lasting changes in mesocorticolimbic dopamine and that drug-induced or idiopathic anomalies in mesocorticolimbic dopamine may underpin vulnerability/resiliency to MA addiction.Keywords
This publication has 97 references indexed in Scilit:
- A genetic animal model of differential sensitivity to methamphetamine reinforcementNeuropharmacology, 2012
- Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intakeNeuropharmacology, 2012
- Distinct Neurochemical Adaptations Within the Nucleus Accumbens Produced by a History of Self-Administered vs Non-Contingently Administered Intravenous MethamphetamineNeuropsychopharmacology, 2011
- Neurologic Manifestations of Chronic Methamphetamine AbuseNeurologic Clinics, 2011
- Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intakeGenes, Brain and Behavior, 2011
- Genetically correlated effects of selective breeding for high and low methamphetamine consumptionGenes, Brain and Behavior, 2009
- Extended Methamphetamine Self-Administration in Rats Results in a Selective Reduction of Dopamine Transporter Levels in the Prefrontal Cortex and Dorsal Striatum Not Accompanied by Marked Monoaminergic DepletionThe Journal of Pharmacology and Experimental Therapeutics, 2009
- The incentive sensitization theory of addiction: some current issuesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Dopamine and reward: The anhedonia hypothesis 30 years onNeurotoxicity Research, 2008
- Behavioral genetic contributions to the study of addiction-related amphetamine effectsNeuroscience & Biobehavioral Reviews, 2008